Staging of non-small cell lung cancer: consensus, controversies and challenges.

  title={Staging of non-small cell lung cancer: consensus, controversies and challenges.},
  author={Jan P A M van Meerbeeck},
  journal={Lung cancer},
  volume={34 Suppl 2},
Stage is with performance status, the most potent prognostic factor in non-small cell lung cancer. In the past decades, much effort has been directed towards the definition, description, development and implementation of staging guidelines. This has undoubtedly resulted in improvements in therapy and insight in the biology of the disease. The new millennium sees us confronted with an increasing epidemic of lung cancer. Hence, the need for further improvements in staging accuracy and cost… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 17 extracted citations

The role of microRNA in metastatic processes of non-small cell lung carcinoma.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia • 2016
View 6 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…